Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Naproxen Codeine in Arthroscopic Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01952652
Recruitment Status : Completed
First Posted : September 30, 2013
Last Update Posted : September 30, 2013
Sponsor:
Information provided by (Responsible Party):
CAGLA BALI,MD, Baskent University

Brief Summary:
In this study, the aim is to compare the efficacy of single dose naproxen sodium and combination of naproxen sodium-codeine phosphate on post-operative pain in adult patients undergoing arthroscopic menisectomy.Pre-emptive oral naproxen-codeine may be safely and more advantageous than naproxen alone.

Condition or disease Intervention/treatment Phase
Arthroscopic Meniscus Surgery Drug: Group N:Naproxen sodium Drug: Group NC :naproxen sodium codeine phosphate Phase 4

Detailed Description:
Patients receiving preemptive oral naproxen sodium (Group N) or naproxen sodium-codeine phosphate (Group NC) were assigned in 2 groups.Preoperatively, drugs were given orally by a nurse unaware of the study to both groups within 60 minutes before surgery. Hemodynamic datas, possible side effects, pain and sedation levels of patients were recorded. Patient's pain and sedation levels were statistically assessed.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 61 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Comparison of Post-operative Analgesic Effects of Naproxen Sodium and Naproxen Sodium-codeine Phosphate Administered Preemptively for Arthroscopic Meniscus Surgery
Study Start Date : January 2013
Actual Primary Completion Date : June 2013
Actual Study Completion Date : July 2013

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Group Naproxen sodium (Group N)
Group N received naproxen sodium 550 mg 60 minutes before surgery.
Drug: Group N:Naproxen sodium
drug will be given 60 minutes before surgery
Other Name: Apranax fort tb, Abdi Ibrahim Ilaç,Turkiye

Active Comparator: Group Naproxen sodium codeine phosphate (Group NC)
Group NC received naproxen sodium 550 mg+30 mg codeine 60 minutes before surgery.
Drug: Group NC :naproxen sodium codeine phosphate
drug will be given 60 minutes before surgery
Other Name: Apranax plus tb, Abdi Ibrahim Ilac, Turkey




Primary Outcome Measures :
  1. Pain scores as measured by Visual Analogue Scale were significantly lower in Group Naproxen codeine (group NC) at all time points compared to Group Naproxen (group N) in 61 patients who underwent arthroscopic meniscus surgery. [ Time Frame: postoperative 18 hours ]
    patients will be followed postoperatively 18 hours for pain levels



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 60 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients undergoing arthroscopic meniscectomy were included in the study.

Exclusion Criteria:

  • ≤ 18 years of age
  • hypersensitivity to non-steroidal anti-inflammatory drugs and codeine,
  • history of peptic ulcer, gastritis, upper gastrointestinal bleeding
  • coagulation disorder
  • serious hepatic and renal impairment
  • pregnancy
  • long-term NSAID and opioid use

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01952652


Locations
Layout table for location information
Turkey
Baskent University School of Medicine Adana Teaching and Research Hospital
Adana, Turkey, 01250
Sponsors and Collaborators
Baskent University
Investigators
Layout table for investigator information
Study Director: Anis Aribogan, Prof.,MD Baskent University School of Medicine

Layout table for additonal information
Responsible Party: CAGLA BALI,MD, MD,Anesthesiology and Reanimation, Baskent University
ClinicalTrials.gov Identifier: NCT01952652     History of Changes
Other Study ID Numbers: KA12/268
First Posted: September 30, 2013    Key Record Dates
Last Update Posted: September 30, 2013
Last Verified: September 2013
Keywords provided by CAGLA BALI,MD, Baskent University:
Naproxen-codeine
preemptive analgesia
day case surgery
Additional relevant MeSH terms:
Layout table for MeSH terms
Naproxen
Codeine
Anti-Inflammatory Agents, Non-Steroidal
Analgesics, Non-Narcotic
Analgesics
Sensory System Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Anti-Inflammatory Agents
Antirheumatic Agents
Gout Suppressants
Cyclooxygenase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Analgesics, Opioid
Narcotics
Central Nervous System Depressants
Antitussive Agents
Respiratory System Agents